GLP-1 RA Use and Survival Among Older Adults With Cancer and Type 2 Diabetes
Rotana M. Radwan, Ying Lü, Hao Dai, Thomas J. George, Yi Guo, Jingchuan Guo, Jiang Bian
Abstract
This cohort study evaluates whether older adults with type 2 diabetes and cancer have improved survival when taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) compared with sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors.
Topics & Concepts
Type 2 diabetesDipeptidyl peptidase-4MedicineGlucagon-like peptide 1 receptorCancerCohortDiabetes mellitusGlucagon-like peptide-1Internal medicineOncologyGerontologyEndocrinologyReceptorAgonistDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerNeuroendocrine Tumor Research Advances